SPECIES-DIFFERENCES IN THE DEAMINATION OF DOPAMINE AND OTHER SUBSTRATES FOR MONOAMINE-OXIDASE IN BRAIN

被引:122
作者
GARRICK, NA [1 ]
MURPHY, DL [1 ]
机构
[1] NIMH,CLIN NEUROPHARMACOL BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1007/BF00433804
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:27 / 33
页数:7
相关论文
共 33 条
[1]   POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH ;
LINAUER, W .
JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326
[2]   MONOAMINE OXIDASE-B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION [J].
BRAESTRUP, C ;
ANDERSEN, H ;
RANDRUP, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) :181-187
[3]   EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONO-AMINE METABOLISM IN THE RAT-BRAIN [J].
CAMPBELL, IC ;
ROBINSON, DS ;
LOVENBERG, W ;
MURPHY, DL .
JOURNAL OF NEUROCHEMISTRY, 1979, 32 (01) :49-55
[4]  
CROSS AJ, 1978, P BPS BRIT J PHARMAC, V63, P408
[5]  
DEMAREST KT, 1979, MONOAMINE OXIDASE ST, P423
[6]   SUBSTRATE-RELATED AND INHIBITOR-RELATED CHARACTERISTICS OF HUMAN PLATELET MONOAMINE-OXIDASE [J].
DONNELLY, CH ;
MURPHY, DL .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (09) :853-858
[7]   PROPERTIES OF MONOAMINE-OXIDASE IN MOUSE NEUROBLASTOMA N1E-115 CELLS [J].
DONNELLY, CH ;
RICHELSON, E ;
MURPHY, DL .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (14) :1639-1643
[8]   CHARACTERISTICS OF MONO-AMINE OXIDASES IN BRAIN AND OTHER ORGANS OF GOLDEN-HAMSTER [J].
EDWARDS, DJ ;
MALSBURY, CW .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (06) :959-963
[9]   MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].
FOWLER, CJ ;
CALLINGHAM, BA ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101
[10]  
GARRICK NA, 1979, MONOAMINE OXIDASE ST, P351